Relative Value Partners Group’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-123,612
Closed -$1.89M 336
2024
Q1
$1.89M Sell
123,612
-1,238
-1% -$19.2K 0.12% 113
2023
Q4
$1.87M Sell
124,850
-928
-0.7% -$13.5K 0.11% 115
2023
Q3
$1.82M Sell
125,778
-82,978
-40% -$1.24M 0.12% 112
2023
Q2
$3.18M Sell
208,756
-203,008
-49% -$3.05M 0.21% 83
2023
Q1
$6.23M Sell
411,764
-86,055
-17% -$1.28M 0.43% 55
2022
Q4
$6.9M Buy
497,819
+345,980
+228% +$4.88M 0.49% 44
2022
Q3
$2.07M Buy
151,839
+71,851
+90% +$1.07M 0.17% 90
2022
Q2
$1.24M Buy
79,988
+36,142
+82% +$558K 0.09% 118
2022
Q1
$726K Sell
43,846
-4,059
-8% -$71.3K 0.05% 155
2021
Q4
$932K Buy
+47,905
New +$931K 0.07% 107

Other funds holding BCAT

Relative Value Partners Group's BCAT Position: Q2 2024 in Review

Relative Value Partners Group sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2024, closing a stake of 123,612 shares — an estimated $1.89M sold.

Relative Value Partners Group first reported a position in BCAT in Q4 2021 and held it in 10 quarters. The position peaked at $6.9M in Q4 2022. 86 funds tracked by Wall St. Rank hold BCAT as of Q2 2024.

  • Relative Value Partners Group reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2024 after selling out during the quarter.
  • Relative Value Partners Group sold 123,612 BlackRock Capital Allocation Term Trust shares in Q2 2024, an estimated $1.89M.
  • Relative Value Partners Group first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and held it in 10 quarters.
  • Relative Value Partners Group's BlackRock Capital Allocation Term Trust position peaked at $6.9M in Q4 2022.
  • 86 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2024.

Based on Relative Value Partners Group's 13F filing for Q2 2024, filed 12 Jul 2024.